AMH and ovarian reserve: what the result does and does not mean

Ovarian reserve concerns the remaining egg supply. It is not the same as egg quality, and a result is not a standalone verdict on future pregnancy.

Separate the questions

AMH and antral follicle count are commonly used measures of ovarian reserve. ASRM distinguishes egg quantity from egg quality and notes that reserve measures are useful for estimating response to ovarian stimulation, but are poor independent predictors of reproductive potential.

Source: ASRM: Testing and interpreting measures of ovarian reserve

Before interpreting a number, clarify which question you are asking: response to a treatment cycle, the reason for a fertility difficulty, or planning a future conversation. Those are not interchangeable.

Avoid turning a result into a countdown

A laboratory result does not contain your whole reproductive history or future. A simple “good” or “bad” label can hide the exact decision for which the measurement was ordered.

01Was this ordered to help plan treatment, investigate a problem, or provide general information?

02What does this result mean in my particular clinical context?

03What does it not tell us about egg quality or a future pregnancy?

04Would repeating it change the decision, and under what circumstances?

Do not change reproductive plans on the basis of a promotional “fertility score” alone. Bring the report to a qualified clinician who can explain the intended use and limitations.

Fertility evaluation looks beyond one marker

A fertility evaluation is tailored to the person and may consider ovulation, reproductive anatomy, and a partner’s semen assessment when relevant. ASRM describes ovarian reserve testing as an adjunct in infertility assessment, not a stand-alone screening test for people who do not meet infertility criteria.

Source: ASRM: Fertility evaluation of infertile women

This is why the most useful report is not necessarily the one with the most dramatic graphic. It is the one that makes clear what has been measured, what remains unknown, and how it relates to the next decision.

A calmer way to prepare

01What am I deciding now, and what am I not yet ready to decide?

02What information would make the decision easier?

03Which questions require a fertility specialist rather than a consumer test?

04What costs, timelines, and alternatives should I understand before considering treatment?

Our fertility planning consultation guide turns these into a one-page discussion outline. There is no requirement to have a fixed family plan before asking questions.

Nova Arc’s boundary

This article does not claim that Nova Arc measures egg quality, predicts natural conception, guarantees IVF outcomes, or identifies an exact date of menopause. The platform is in development. Product performance needs evidence, not an analogy or a persuasive score.

Return to fertility planning for more education, or read how testing differs in perimenopause.

Sources and scope

Sources are provided so you can check the guidance directly. This article is educational, not individualized advice. Nova Arc publishes this library and is developing a commercial ovarian-health product. No partnership with, or endorsement by, the linked organizations is implied.